Document is current
Any future updates will be listed below
-
Authors
Liu, Yun
Zhang, Bo
Xu, Jianping
Wang, Xingyuan
Tang, Jialin
Huang, Jing https://orcid.org/0000-0002-2167-8385
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04088604 at ClinicalTrials.govDocuments that mention this clinical trial
Phase I study of liposomal irinotecan (LY01610) in patients with advanced esophageal squamous cell carcinoma
https://doi.org/10.1007/s00280-021-04294-2
- License Information
-
More Information
Article History
Received: 20 January 2021
Accepted: 15 May 2021
First Online: 24 May 2021
Declarations
:
: The author(s) declare that they have no conflict of interest.
: This study was conducted in accordance with the principles of the Declaration of Helsinki and the International Conference on Harmonization Guidelines for Good Clinical Practice. The study protocol was approved by the ethics committee. Informed consent was obtained from all individual participants included in the study.
